Tuebingen, Germany

Sarah Kutscher

USPTO Granted Patents = 11 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2022-2024

Loading Chart...
11 patents (USPTO):Explore Patents

Title: Sarah Kutscher: Pioneering Immunotherapy Inventor

Introduction:

Sarah Kutscher is a trailblazing inventor hailing from Tuebingen, Germany. With a remarkable portfolio of 11 patents under her belt, Kutscher has been at the forefront of revolutionizing immunotherapy against hepatocellular carcinoma (HCC) and various other cancers.

Latest Patents:

Among Kutscher's latest patents is a groundbreaking innovation involving peptides and their combinations for robust immunotherapy targeting HCC. These peptides, such as the amino acid sequences GLIHLEGDTV (SEQ ID NO: 53) and GVLPGLVGV (SEQ ID NO: 56), have shown the ability to bind to MHC class-I molecules, facilitating recognition by CD8 T cells. The compositions containing these peptides along with adjuvants and carriers hold great promise in the fight against cancer.

Career Highlights:

Sarah Kutscher is currently contributing her expertise to Immatics Biotechnologies GmbH, a leading biotech company known for its cutting-edge research in the field of immunotherapy. Her innovative spirit and dedication to advancing healthcare solutions have positioned her as a key figure in the company's R&D efforts.

Collaborations:

In her impactful journey, Kutscher has collaborated closely with esteemed colleagues such as Andrea Mahr and Toni Weinschenk. Together, they have worked tirelessly to translate scientific discoveries into tangible advancements in cancer treatment, paving the way for a more effective immunotherapeutic approach.

Conclusion:

Sarah Kutscher's unwavering commitment to innovation and her significant contributions to the realm of immunotherapy exemplify her as a true visionary in the field. Her patents and collaborations stand as a testament to her dedication to improving patient outcomes and reshaping the landscape of cancer treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…